Mark D. Erickstad, MD

Urology in Longview, TX

1300 N 4th St, Longview, TX 75601 · Texas Oncology PA
NPI 1972570307 Accepts Medicare assignment 40 years since graduation Public record — not managed by the clinician

About Dr. Mark Erickstad

Dr. Mark Erickstad is a physician specializing in urology practicing in Longview, TX, a graduate of University of Texas Southwestern Medical School at Dallas (1986). Affiliated with Christus Health-Mount Pleasant, Longview Regional Medical Center, Ut Health East Texas Carthage Hospital. Treated 846 Medicare patients in 2024.

SpecialtyUrologyOther urology doctors in Longview
CredentialsMD
EducationUniversity of Texas Southwestern Medical School at Dallas, 1986CMS Doctors and Clinicians
GenderMale
NPI number1972570307National Provider Identifier (CMS NPPES), issued March 2006
MedicareEnrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians

Where Dr. Mark Erickstad practices

Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.

Dr. Mark Erickstad's specialties and state licenses

Specialty (NPPES)License
Urology PrimaryTX H2362

As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.

Hospital affiliations of Dr. Mark Erickstad

  • Christus Health-Mount PleasantHospital · Mount Pleasant, TX
  • Longview Regional Medical CenterHospital · Longview, TX
  • Ut Health East Texas Carthage HospitalHospital · Carthage, TX

CMS Facility Affiliation data: facilities where the clinician bills Medicare.

Dr. Mark Erickstad's Medicare patients and services (2024)

846Medicare patients
11,372services billed
76average patient age
29%women

Most frequent services

ServiceTimesAvg. Medicare allowed
Automated urinalysis test1,334$2.19
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more957$122.18
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's848$15.75
Ultrasound measurement of bladder capacity after voiding260$10.50
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more234$86.82
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more216$53.80
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more145$159.80
Insertion of needle into vein for collection of blood sample113$8.65

Common conditions among these patients

  • High cholesterol75%
  • High blood pressure75%
  • Arthritis51%
  • Diabetes36%
  • Ischemic heart disease36%
  • Chronic kidney disease27%

Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.

Dr. Mark Erickstad's Medicare quality score (MIPS 2024)

85.1/100final MIPS score
67.5quality
100promoting interoperability
40improvement activities

The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as apm. Source: CMS Care Compare, PY 2024 clinician public reporting.

Payments from drug and device companies to Dr. Mark Erickstad (2025)

$283.05 in 12 general payments reported in 2025.

TypePaymentsAmount
Food and beverage12$283.05

Paying companies: Sumitomo Pharma America, Inc. ($80.33), Teleflex LLC ($33.62), Astellas Pharma US Inc ($33.42), NOVARTIS PHARMACEUTICALS CORPORATION ($31.90), BIOPROTECT MEDICAL, INC. ($26.81), UroGen Pharma, Inc. ($22.54).

Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.

Questions about Dr. Mark Erickstad

What kind of clinician is Dr. Mark Erickstad?

Dr. Mark Erickstad is listed as a physician specializing in urology.

Where does Dr. Mark Erickstad practice?

Texas Oncology PA at 1300 N 4th St, Longview, TX 75601.

What is the office phone number for Dr. Mark Erickstad?

The listed office number is (903) 757-2122. Call to confirm availability and whether new patients are accepted.

What is the NPI number of Dr. Mark Erickstad?

The National Provider Identifier is 1972570307.

Does Dr. Mark Erickstad accept Medicare?

Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.

Which hospitals is Dr. Mark Erickstad affiliated with?

Christus Health-Mount Pleasant, Longview Regional Medical Center, Ut Health East Texas Carthage Hospital.

Where did Dr. Mark Erickstad go to medical school?

University of Texas Southwestern Medical School at Dallas, graduating in 1986.

Where this information comes from

CMS Doctors and CliniciansName, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026)
NPPES NPI registryNPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2015-05-18
Facility affiliationsHospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services
Medicare utilizationPatients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024
MIPSQuality payment program scores.CMS clinician public reporting, PY 2024
Open PaymentsPayments from drug and device companies.CMS Open Payments, program year 2025

Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.

0 clinics selected Compare